JAPAN’S EISAI CO. DEVELOPS NEW DRUG FOR ALZHEIMER DISEASE

Highlights – Japan’s Eisai Co. develops new drug for Alzheimer disease. The drug has been developed with U.S. firm Biogen Inc. The U.S. Food and Drug Administration on Monday approved of the new drug named ‘Aduhelm’. Aduhelm reduces amyloid beta…